Pancreatic Incidentalomas: Review and Current Management Recommendations

Abstract

There has been significant increase in the detection of incidental pancreatic lesions due to widespread use of cross-sectional imaging like computed tomography and magnetic resonance imaging supplemented with improvements in imaging resolution. Hence, accurate diagnosis (benign, borderline, or malignant lesion) and adequate follow-up is advised for these incidentally detected pancreatic lesions. In this article, we would review the various pancreatic parenchymal (cystic or solid) and ductal lesions (congenital or pathological), discuss the algorithmic approach in management of incidental pancreatic lesions, and highlight the key imaging features for accurate diagnosis.

Keywords

duct - incidentaloma - pancreas - pancreatic cyst

• References

• 1 Tsuda S. Pancreatic Incidentaloma [Internet]. (updated 2013 June 06; cited 2017 April 09). Available at: https://www.sages.org/wiki/pancreatic-incidentaloma . Accessed July 10, 2019
• 2 Kostiuk TS. Observation of pancreatic incidentaloma [in Russian]. Klin Khir 2001; 9 (09) 62-63
• 3 de Jong K, Nio CY, Hermans JJ. et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010; 8 (09) 806-811
• 4 Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 2002; 223 (02) 547-553
• 5 Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y. Analysis of small cystic lesions of the pancreas. Int J Pancreatol 1995; 18 (03) 197-206
• 6 Winter JM, Cameron JL, Lillemoe KD. et al. Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg 2006; 243 (05) 673-680
• 7 Pantoja M, Salazar M, Vela'zquez-Ferna'ndez D. Pancreatic incidentaloma. In: Hubbard JGH, Inabnet WB, Lo CY. eds. Endocrine Surgery: Principles and Practice (Springer Specialist Surgery Series). 1st ed.. London: Springer; 2009
• 8 Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: clinico-pathologic characteristics and comparison with symptomatic patients. Arch Surg 2003; 138 (04) 427-433
• 9 Allen PJ, D'Angelica M, Gonen M. et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006; 244 (04) 572-582
• 10 Allen PJ, Jaques DP, D'Angelica M, Bowne WB, Conlon KC, Brennan MF. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg 2003; 7 (08) 970-977
• 11 Sureka B, Bihari C, Arora A. et al. JOP. 2016; 17: 452-465
• 12 Curry CA, Eng J, Horton KM. et al. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment?. Am J Roentgenol 2000; 175 (01) 99-103
• 13 Bagci P, Andea AA, Basturk O, Jang KT, Erbarut I, Adsay V. Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia. Mod Pathol 2012; 25 (03) 439-448
• 14 Horvath KD, Chabot JA. An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 1999; 178 (04) 269-274
• 15 Mathieu D, Guigui B, Valette PJ. et al. Pancreatic cystic neoplasms. Radiol Clin North Am 1989; 27 (01) 163-176
• 16 Taouli B, Vilgrain V, Vullierme MP. et al. Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation. Radiology 2000; 217 (03) 757-764
• 17 Klöppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 2001; 1 (06) 648-655
• 18 Nygaard KK, Walters W. Polycystic disease of the pancreas (dysontogenetic cysts): report of a case with partial pancreatectomy. Ann Surg 1937; 106 (01) 49-53
• 19 Rodrigues-Pinto E, Pereira P, Cunha R, Macedo G. Pancreatic dysontogenetic cysts. Rev Esp Enferm Dig 2014; 106 (07) 477-478
• 20 Hammel PR, Vilgrain V, Terris B. et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000; 119 (04) 1087-1095
• 21 van Asselt SJ, de Vries EG, van Dullemen HM. et al. Pancreatic cyst development: insights from von Hippel-Lindau disease. Cilia 2013; 2 (01) 3
• 22 Kim JA, Blumenfeld JD, Chhabra S. et al. Pancreatic cysts in autosomal dominant polycystic kidney disease: prevalence and association with PKD2 gene mutations. Radiology 2016; 280 (03) 762-770
• 23 Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med 2009; 60: 321-337
• 24 Chapman AB, Devuyst O, Eckardt KU. et al; Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015; 88 (01) 17-27
• 25 Palmucci S, Trombatore C, Foti PV. et al. The utilization of imaging features in the management of intraductal papillary mucinous neoplasms. Gastroenterol Res Pract 2014; 2014: 765451
• 26 Ren F, Zuo C, Chen G. et al. Pancreatic retention cyst: multi-modality imaging findings and review of the literature. Abdom Imaging 2013; 38 (04) 818-826
• 27 Wolfson D, Barkin JS, Chari ST. et al. Management of pancreatic masses. Pancreas 2005; 31 (03) 203-217
• 28 Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995; 332 (22) 1482-1490
• 29 Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355 (25) 2670-2676
• 30 McMahon PM, Halpern EF, Fernandez-del Castillo C, Clark JW, Gazelle GS. Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability. Radiology 2001; 221 (01) 93-106
• 31 Nichols MT, Russ PD, Chen YK. Pancreatic imaging: current and emerging technologies. Pancreas 2006; 33 (03) 211-220
• 32 Saisho H, Yamaguchi T. Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas 2004; 28 (03) 273-278
• 33 Lopez HänninenE, Amthauer H, Hosten N. et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 2002; 224 (01) 34-41
• 34 Kalra MK, Maher MM, Boland GW, Saini S, Fischman AJ. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications. Am J Roentgenol 2003; 181 (02) 387-393
• 35 Cwik G, Wallner G, Skoczylas T, Ciechanski A, Zinkiewicz K. Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. Arch Surg 2006; 141 (10) 968-973
• 36 Yao JC, Hassan M, Phan A. et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26 (18) 3063-3072
• 37 Bettini R, Boninsegna L, Mantovani W. et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008; 19 (05) 903-908
• 38 Brentjens R, Saltz L. Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 2001; 81 (03) 527-542
• 39 Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25 (03) 458-511
• 40 Debray MP, Geoffroy O, Laissy JP. et al. Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 2001; 74 (887): 1065-1070
• 41 Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000; 214 (02) 483-490
• 42 Semelka RC, Custodio CM, Cem BalciN, Woosley JT. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 2000; 11 (02) 141-148
• 43 Gambill EE. Pancreatitis associated with pancreatic carcinoma: a study of 26 cases. Mayo Clin Proc 1971; 46 (03) 174-177
• 44 McKay CJ, Glen P, McMillan DC. Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol 2008; 22 (01) 65-73
• 45 Megibow AJ, Bosniak MA, Ambos MA, Beranbaum ER. Thickening of the celiac axis and/or superior mesenteric artery: a sign of pancreatic carcinoma on computed tomography. Radiology 1981; 141 (02) 449-453
• 46 Luetmer PH, Stephens DH, Fischer AP. Obliteration of periarterial retropancreatic fat on CT in pancreatitis: an exception to the rule. Am J Roentgenol 1989; 153 (01) 63-64
• 47 Frampas E, Morla O, Regenet N, Eugène T, Dupas B, Meurette G. A solid pancreatic mass: tumour or inflammation?. Diagn Interv Imaging 2013; 94 (07) [phone]
• 48 Kim T, Murakami T, Takamura M. et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. Am J Roentgenol 2001; 177 (02) 367-371
• 49 Kajiwara M, Gotohda N, Konishi M. et al. Incidence of the focal type of autoimmune pancreatitis in chronic pancreatitis suspected to be pancreatic carcinoma: experience of a single tertiary cancer center. Scand J Gastroenterol 2008; 43 (01) 110-116
• 50 Manfredi R, Graziani R, Cicero C. et al. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 2008; 247 (02) 435-443
• 51 Learn PA, Grossman EB, Do RK. et al. Pitfalls in avoiding operation for autoimmune pancreatitis. Surgery 2011; 150 (05) 968-974
• 52 Türkvatan A, Erden A, Türkoğlu MA, Yener Ö. Congenital variants and anomalies of the pancreas and pancreatic duct: imaging by magnetic resonance cholangiopancreaticography and multidetector computed tomography. Korean J Radiol 2013; 14 (06) 905-913
• 53 Schulte SJ. Embryology, normal variation, and congenital anomalies of the pancreas. In: Stevenson GW, Freeny PC, Margulis AR, Burhenne HJ. eds. Margulis and Burhenne's Alimentary Tract Radiology. 5th ed.. St. Louis, MO: Mosby; 1994: 1039-1051
• 54 Graziani R, Frulloni L, Cicero C. et al. Bull's-eye pattern of pancreatic-duct stones on multidetector computed tomography and gene-mutation-associated pancreatitis (GMAP). Radiol Med (Torino) 2012; 117 (08) 1275-1286
• 55 Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339 (10) 653-658
• 56 Wilson RW, Gal AA, Cohen C, DeRose PB, Millikan WJ. Serotonin immunoreactivity in pancreatic endocrine neoplasms (carcinoid tumors). Mod Pathol 1991; 4 (06) 727-732
• 57 Druce M, Rockall A, Grossman AB. Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol 2009; 5 (05) 276-283
• 58 Kawamoto S, Shi C, Hruban RH. et al. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. Am J Roentgenol 2011; 197 (03) W482-8
• 59 Stratilatovas E, Sangaila E, Cicenas S. Radical surgery for large-sized slow-growing neuroendocrine tumor of the pancreas. J BUON 2002; 7 (04) 381-383
• 60 Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 2010; 14 (03) 541-548
• 61 Karatzas T, Dimitroulis D, Charalampoudis P, Misiakos EP, Vasileiadis I, Kouraklis G. Management of cystic and solid pancreatic incidentalomas: a review analysis. J BUON 2013; 18 (01) 17-24
• 62 Hol L, Bruno MJ, Cahen DL. Follow-up of asymptomatic pancreatic cysts in clinical practice: a vignette questionnaire. Pancreatology 2016; 16 (03) 416-422
• 63 Vege SS, Ziring B, Jain R, Moayyedi P. Clinical Guidelines Committee; American Gastroenterology Association. American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015; 148 (04) 819-822
• 64 Tanaka M, Fernández-Del Castillo C, Kamisawa T. et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17 (05) 738-753
• 65 Del Chiaro M, Verbeke C, Salvia R. et al; European Study Group on Cystic Tumours of the Pancreas. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013; 45 (09) 703-711